LDR BURST Trial

Cross-source consensus on LDR BURST Trial from 1 sources and 5 claims.

1 sources · 5 claims

Comparisons

Other

Highlighted claims

The trial randomizes 220 participants equally between LDR brachytherapy plus Barrigel and five-fraction SBRT plus Barrigel. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
The trial requires treatment to begin within 8 weeks of randomization and no later than week 12. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
The LDR BURST trial is a randomized controlled trial comparing LDR brachytherapy with five-fraction SBRT when rectal spacer gel is used in both treatment arms. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
The trial is a single-centre parallel-group interventional RCT conducted at Royal Surrey County Hospital with planned multicentre expansion. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer
Treatment allocation is not blinded for participants and treating clinicians, but outcome assessors are blinded during final analysis. — The LDR BURST trial: a randomised controlled trial comparing the side effects of low-dose-rate brachytherapy against ultra-hypofractionated radiotherapy using spacer gel treatment in men with Cambridge Prognostic Groups 1–3 prostate cancer